Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.
Monoclonal-antibody (MAb)-resistant mutants were used to map antigenic sites on foot-and-mouth disease virus (FMDV), which resulted in the identification of neutralizing epitopes in the flexible βG-βH loop in VP1. For FMDV SAT2 viruses, studies have shown that at least two antigenic sites exist. By use of an infectious SAT2 cDNA clone, 10 structurally exposed and highly variable loops were identified as putative antigenic sites on the VP1, VP2, and VP3 capsid proteins of SAT2/Zimbabwe (ZIM)/7/83 (topotype II) and replaced with the corresponding regions of SAT2/Kruger National Park (KNP)/19/89 (topotype I). Virus neutralization assays using convalescent-phase antisera raised against the parental virus, SAT2/ZIM/7/83, indicated that the mutant virus containing the TQQS-to-ETPV mutation in the N-terminal part of the βG-βH loop of VP1 showed not only a significant increase in the neutralization titer but also an increase in the index of avidity to the convalescent-phase antisera. Furthermore, antigenic profiling of the epitope-replaced and parental viruses with nonneutralizing SAT2-specific MAbs led to the identification of two nonneutralizing antigenic regions. Both regions were mapped to incorporate residues 71 to 72 of VP2 as the major contact point. The binding footprint of one of the antigenic regions encompasses residues 71 to 72 and 133 to 134 of VP2 and residues 48 to 50 of VP1, and the second antigenic region encompasses residues 71 to 72 and 133 to 134 of VP2 and residues 84 to 86 and 109 to 11 of VP1. This is the first time that antigenic regions encompassing residues 71 to 72 of VP2 have been identified on the capsid of a SAT2 FMDV.


OBJECTIVE
Monoclonal-antibody-resistant mutants have traditionally been used to map antigenic sites on foot-and-mouth disease virus (FMDV). However, for SAT2-type viruses, which are responsible for most of the FMD outbreaks in Africa and are the most varied of all seven serotypes, only two antigenic sites have been identified. We have followed a unique approach using an infectious SAT2 cDNA genome-length clone. Ten structurally surface-exposed, highly varied loops were identified as putative antigenic sites on the VP1, VP2, and VP3 capsid proteins of the SAT2/ZIM/7/83 virus. These regions were replaced with the corresponding regions of an antigenically disparate virus, SAT2/KNP/19/89. Antigenic profiling of the epitope-replaced and parental viruses with SAT2-specific MAbs led to the identification of two unique antibody-binding footprints on the SAT2 capsid. In this report, evidence for the structural engineering of antigenic sites of a SAT2 capsid to broaden cross-reactivity with antisera is provided.
Onderstepoort Veterinary Institute, Transboundary Animal Diseases Programme, Onderstepoort, South Africa Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, South Africa.
Pamela A
PA
Opperman
Onderstepoort Veterinary Institute, Transboundary Animal Diseases Programme, Onderstepoort, South Africa.
Lia S
LS
Rotherham
Onderstepoort Veterinary Institute, Transboundary Animal Diseases Programme, Onderstepoort, South Africa.
Jan
J
Esterhuysen
The Pirbright Institute, Woking, United Kingdom.
Bryan
B
Charleston
The Pirbright Institute, Woking, United Kingdom.
Nicholas
N
Juleff
INTA, Instituto de Virología, Centro de Investigaciones en Ciencias Veterinarias y Agronómicas, Buenos Aires, Argentina.
Alejandra V
AV
Capozzo
Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, South Africa.
Jacques
J
Theron
Onderstepoort Veterinary Institute, Transboundary Animal Diseases Programme, Onderstepoort, South Africa Department of Microbiology and Plant Pathology, University of Pretoria, Pretoria, South Africa MareeF@arc.agric.za.
Francois F
FF
Maree
D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D000914:Antibodies, Viral / Q000276:immunology; D000915:Antibody Affinity; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology*; D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology*; D002417:Cattle; D002460:Cell Line; D018604:Epitope Mapping; D029544:Foot-and-Mouth Disease Virus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D016056:Immunodominant Epitopes / Q000235:genetics / Q000276:immunology*; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D015030:Zimbabwe
D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; D016056:Immunodominant Epitopes